1. In vitro characterisation of Ro 46-8443, the first non-peptide antagonist selective for the endothelin ETB receptor
- Author
-
Werner Neidhart, Martine Clozel, Volker Breu, Georges Hirth, Henri Ramuz, and Kaspar Burri
- Subjects
Endothelin Receptor Antagonists ,Endothelin receptor type A ,Non peptide antagonist ,Receptors, Peptide ,Biophysics ,CHO Cells ,Viper Venoms ,Pharmacology ,In Vitro Techniques ,Endothelin ETA receptor ,Biochemistry ,Binding, Competitive ,Endothelin ,Endothelin antagonist ,Structural Biology ,Cricetinae ,Microsomes ,Genetics ,Animals ,Humans ,Vasoconstrictor Agents ,Molecular Biology ,Etb receptor ,Sulfonamides ,Arachidonic Acid ,Molecular Structure ,Chemistry ,Receptors, Endothelin ,Rightward shift ,Cell Membrane ,Antagonist ,Cell Biology ,respiratory system ,musculoskeletal system ,Endothelin 1 ,Receptor, Endothelin B ,In vitro ,Recombinant Proteins ,Rats ,Pyrimidines ,Vasoconstriction ,cardiovascular system ,Endothelin receptor ,Endothelin ETB receptor ,Muscle Contraction ,Protein Binding ,circulatory and respiratory physiology - Abstract
We describe here Ro 46-8443, the first non-peptide endothelin ETB receptor selective antagonist. It displays up to 2000-fold selectivity for ETB receptors both in terms of binding inhibitory potency and functional inhibition. The observed parallel rightward shift of concentration-response curves with different antagonist concentrations is consistent with a competitive binding mode. Since Ro 46-8443 selectively inhibits ETB receptor mediated responses, it is a valuable tool for clarifying the role of ETB receptors in pathology.
- Full Text
- View/download PDF